Clinical Trial

Beta-3 Enhanced Autonomic Therapy for POTS

Name: Beta-3 Enhanced Autonomic Therapy for POTS — clinical trial record (NCT07585513)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BEAT-POTS

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The study will test the hypothesis that mirabegron is more effective than a placebo in alleviating postural orthostatic tachycardia (POTS) symptoms.

Trial Details

NCT Number	NCT07585513
Lead Sponsor	Cedars-Sinai Medical Center
Conditions	Postural Orthostatic Tachycardia Syndrome (POTS)
Enrollment	36 participants
Start Date	2026-05
Primary Completion	2028-05 (estimated)
Study Completion	2028-05 (estimated)
Updated on ClinicalTrials.gov	2026-05-13